2026年3月2日，TATA健康国际控股有限公司（股份代号：01255）公布了截至2026年2月28日的证券变动月报表。报告显示，于本月公司股本结构维持稳定，未有新增发行或回购注销活动。
公司注册股本维持在5,000,000港元（对应每股面值0.01港元，合共500,000,000股），本月无增减变动。截至2月底，公司已发行股份及库存股份数目分别维持在242,845,000股及0股，总已发行股份数同样未作调整。
报告未披露任何期权与激励计划变动，公司当月亦无购回或注销股份事项。公司确认截至报告期末已满足相关公众持股量要求，并继续遵守香港联交所《上市规则》以及其他适用法规。
公告由公司董事张鸣琪签署。公司表示将持续关注股本结构变化，并在有需要时及时披露。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.